RecallRadar

FDA Drug recall D-0455-2025

Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA

On 2025-06-11 the FDA classified a Class II recall of Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA by Torrent Pharma, citing CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0455-2025
ClassificationClass II
Statuscompleted
Initiated2025-05-27
Published2025-06-11
Last updated2026-09-13 11:52 UTC
CompanyTorrent Pharma
DistributionUS

Product

Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-30

Reason

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Identifiers

ndc13668-443-74
ndc13668-443-10
ndc13668-443-01
ndc13668-443-30
ndc13668-443-91
ndc13668-473-10
ndc13668-473-74
ndc13668-473-30
ndc13668-473-01
ndc13668-473-91
code_infoLot# BDX6K001; Exp. Date 06/30/2025

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0455-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.